Hybrid positron emission tomography and magnetic resonance imaging in cardiac sarcoidosis diagnosis: a pilot experience

pp.392-397

Abstract

Background: Recent studies suggest combining the findings of cardiac magnetic resonance (CMR) and positron emission tomography (PET) to increase sensitivity in the diagnosis of cardiac sarcoidosis (CS).
Objective: To evaluate the complementary value of CMR and PET in the diagnosis of CS.
Methods: From December 2018 to July 2020, 6 patients (4 males and 2 females) with suspected CS were referred to our facility for evaluation of myocardial inflammation. A resting 13N Ammonia myocardial perfusion test and a 18F Fluorodeoxyglucose
(FDG) PET were performed to evaluate myocardial inflammation and/or fibrosis. All patients had a previous gadoliniumenhanced CMR.
Results: The average age was 60 ± 9 years. Fifty percent of the patients had a history of systemic sarcoidosis and the remaining 50% had suspected isolated CS. None of the patients had active myocardial inflammation based on the PET findings. With the combination of PET patterns and enhanced CMR, the patients were reclassified as follows: 50% had less than 10% chance
of having CS and the other 50% was classified as possible cases of CS. None of the patients received immunosuppressants.
Conclusion: In our patient population with suspected CS and inflammation, we conducted a PET study following a CMR to assess the potential for CS. In the absence of a gold standard, it is suggested that the diagnosis of CS should be based on probabilities according to specific imaging patterns and clinical features.

How to cite this article:

Rodríguez MI, Merani MF, Gallo JC, López de Munaín MN, Campisi R. Hybrid positron emission tomography and magnetic resonance imaging in cardiac sarcoidosis diagnosis: a pilot experience. Rev Argent Cardiol 90;2022:392-7.

http://dx.doi.org/10.7775/rac.v90.i6.20573